Gordon Sun to Cetuximab
This is a "connection" page, showing publications Gordon Sun has written about Cetuximab.
Connection Strength
0.145
-
Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States. Am J Clin Oncol. 2018 Jan; 41(1):65-72.
Score: 0.145
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.